Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy

被引：0
|
作者：
Ismail Sari
Omer Binicier
Merih Birlik
Servet Akar
Erkan Yilmaz
Aydanur Kargi
Fatos Onen
Nurullah Akkoc
机构：
[1] Dokuz Eylul University School of Medicine,Department of Internal Medicine, Division of Rheumatology
[2] Dokuz Eylul University School of Medicine,Department of Radiology
[3] Dokuz Eylul University School of Medicine,Department of Pathology
[4] Dokuz Eylul Universitesi Tip Fakultesi Ic hastaliklari ABD Immunoloji-Romatoloji,undefined
来源：
Rheumatology International | 2009年 / 29卷
关键词：
Tumor necrosis factor alpha inhibitors; Adverse effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumor necrosis factor (TNF) alpha inhibitors are effective in the treatment of inflammatory rheumatic diseases. Despite their effectiveness, anti-TNF drugs have some drawbacks such as severe adverse effects including infections and possibly lymphoproliferative disorders. In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement (true thymic hyperplasia), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment. The clinical presentation was highly suggestive of malignancy and the patient underwent diagnostic mediastinoscopy with biopsy.
引用
收藏
相关论文
共 50 条
  • [11] Reaction on a fresh therapy with etanercept after therapy pause with juvenile idiopathic arthritis
    Napp, M.
    Foeldvari, I.
    Michels, H.
    Moebius, D.
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (07): : 637 - 637
  • [12] REDUCTION OF CONCOMITANT TREATMENT UPON THERAPY WITH ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS
    Horneff, G.
    Minden, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 261 - 261
  • [13] Dynamics of Concomitant Therapy in Children with Juvenile Idiopathic Arthritis Treated with Etanercept
    Alexeeva, Ekaterina
    Dvoryakovskaya, Tatiana
    Gladkikh, Victor
    Moskalev, Andrei
    Denisova, Rina
    Isaeva, Ksenia
    Lomakina, Olga
    Soloshenko, Margarita
    Karaseva, Anna
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [14] The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
    SA Alfantaki
    S Stavrou
    A Siamopoulou-Mavridou
    Pediatric Rheumatology, 9 (Suppl 1)
  • [15] Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?
    Hunter, Harriet
    ARCHIVES OF DISEASE IN CHILDHOOD, 2018, 103 (11) : 1087 - 1089
  • [16] Thymic function in juvenile idiopathic arthritis
    Morgan, Thomas A.
    Lorenzi, Alice
    Anderson, Amy
    Catteral, John
    Patterson, Angela M.
    Foster, Helen E.
    Isaacs, John
    RHEUMATOLOGY, 2008, 47 : II28 - II28
  • [17] Thymic function in juvenile idiopathic arthritis
    Lorenzi, A. R.
    Morgan, T. A.
    Anderson, A.
    Catterall, J.
    Patterson, A. M.
    Foster, H. E.
    Isaacs, J. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 983 - 990
  • [18] Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission
    Yubo Cai
    Xiaosheng Liu
    Wenming Zhang
    Jianrong Xu
    Lanfang Cao
    Rheumatology International, 2013, 33 : 2277 - 2282
  • [19] Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis
    Nicolai, R.
    Cortis, E.
    Rava, L.
    Bracaglia, C.
    Pardeo, M.
    Insalaco, A.
    Buonuomo, P. S.
    Tozzi, A. E.
    De Benedetti, F.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2016, 5 (01) : 76 - 79
  • [20] Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission
    Cai, Yubo
    Liu, Xiaosheng
    Zhang, Wenming
    Xu, Jianrong
    Cao, Lanfang
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (09) : 2277 - 2282
12345